Bone Biologics Files Q1 2025 10-Q

Ticker: BBLGW · Form: 10-Q · Filed: May 12, 2025 · CIK: 1419554

Bone Biologics Corp 10-Q Filing Summary
FieldDetail
CompanyBone Biologics Corp (BBLGW)
Form Type10-Q
Filed DateMay 12, 2025
Risk Levelmedium
Sentimentneutral

Sentiment: neutral

Topics: 10-Q, quarterly-report, financials

TL;DR

Bone Biologics dropped its Q1 2025 10-Q. Check financials.

AI Summary

Bone Biologics Corp. filed its Q1 2025 10-Q report on May 12, 2025, for the period ending March 31, 2025. The company, based in Burlington, MA, operates in the orthopedic, prosthetic & surgical appliances & supplies industry. The filing includes financial data for the first quarter of 2025 and comparative periods.

Why It Matters

This filing provides investors with the latest financial performance and operational updates for Bone Biologics Corp. during the first quarter of 2025.

Risk Assessment

Risk Level: medium — As a publicly traded company filing quarterly reports, there are inherent risks associated with its financial performance and market position.

Key Numbers

  • Q1 2025 — Reporting Period (The financial data pertains to the first quarter of 2025.)
  • 20250331 — Period End Date (The report covers financial activities up to this date.)
  • 20250512 — Filing Date (The date the report was officially submitted to the SEC.)

Key Players & Entities

  • Bone Biologics Corp. (company) — Filer of the 10-Q report
  • 20250331 (date) — End of the reporting period
  • 20250512 (date) — Filing date of the report
  • Burlington, MA (location) — Company's business address

FAQ

What is the primary business of Bone Biologics Corp.?

Bone Biologics Corp. operates in the Orthopedic, Prosthetic & Surgical Appliances & Supplies industry, as indicated by its SIC code 3842.

When was this 10-Q report filed?

This 10-Q report was filed on May 12, 2025.

What period does this 10-Q filing cover?

This filing covers the period ending March 31, 2025 (Q1 2025).

Where is Bone Biologics Corp. located?

Bone Biologics Corp. is located at 2 Burlington Woods Drive, Suite 100, Burlington, MA 01803.

What is the SEC file number for Bone Biologics Corp.?

The SEC file number for Bone Biologics Corp. is 001-40899.

Filing Details

This Form 10-Q (Form 10-Q) was filed with the SEC on May 12, 2025 regarding Bone Biologics Corp (BBLGW).

View full filing on EDGAR

View Full Filing

View this 10-Q filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.